Concepedia
Statistics
Publications
24
Citations
1.6K
H-Index
19
Active since
2001
Affiliations
Xencor (United States)(Current)
University of Southern California
Christian-Albrechts-Universität zu Kiel
National Institute of Standards and Technology
Seung Y. Chu is an author at Xencor (United States) specializing in immunology, life sciences, and antibody engineering.
Publications per year
2001–2020
Potent <i>In vitro</i> and <i>In vivo</i> Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia
Holly M. Horton, Matthew J. Bernett, Erik Pong et al. · Cancer Research · 2008 · 271 citations · Full text
Pharmacy, Immunology, Oncology +17
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
Seung Y. Chu, Igor Voštiar, Sher Karki et al. · Molecular Immunology · 2008 · 155 citations
Life Sciences, Cell Biology, Immunology +11
Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
Holly M. Horton, Seung Y. Chu, Elizabeth Ortiz et al. · The Journal of Immunology · 2011 · 144 citations
Life Sciences, Immunology, Pathobiology +17
A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
Gregory L. Moore, Cristina Bautista, Erik Pong et al. · mAbs · 2011 · 103 citations · Full text
Pharmacy, Biotechnology, Immunology +17
The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primates
Jonathan Zalevsky, Irene Leung, Sher Karki et al. · Blood · 2008 · 101 citations · Full text
Life Sciences, Immunology, Pathology +17
1–5 of 24